Evidence map›Paper›PMID 29165794›Full record

ReviewCancer2018

Leptomeningeal metastasis from systemic cancer: Review and update on management.

Nancy Wang, Mia S Bertalan, Priscilla K Brastianos

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07559097 (A Phase I/II, Single-arm, Single-center Clinical Study), which is not on this map. Cited by 130 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 5 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07559097 phase1 / phase2recruitingnot on this mapstarted 2025, after this paper: background citation

A Phase I/II, Single-arm, Single-center Clinical Study: Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung Cancer

TypeinterventionalSponsorHenan Cancer HospitalRan2025 to 2027Enrolled14ConditionsLeptomeningeal Metastasis From Lung CancerArmsMethotrexate-loaded vesicles
3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 5 syntheses or guidelines pooled it, 251 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Pooled it
  5. Non-opioid Analgesics and Emerging Therapies.Cancer treatment and research · 2021
    Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Radiotherapy for intramedullary, leptomeningeal and epidural metastases: outcomes of an unusual and ominous complication.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Risk factors and clinical outcomes associated with leptomeningeal carcinomatosis in gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  15. Observational
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nancy WangDivision of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Mia S BertalanDivision of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.ORCID http://orcid.org/0000-0003-3519-7985
Priscilla K BrastianosDivision of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Harvard University · US

Funding

Training Program in Nervous System TumorsK12CA090354 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PLOTKIN, SCOTT R · 2001 to 2025
$16.3M
NCI NIH HHS K12 CA090354
6 · The paper itself

Abstract

Leptomeningeal metastasis is an uncommon and typically late complication of cancer with a poor prognosis and limited treatment options. Diagnosis is often challenging, with nonspecific presenting symptoms ranging from headache and confusion to focal neurologic deficits, such as cranial nerve palsies. Standard diagnostic evaluation involves a neurologic examination, magnetic resonance imaging of the brain and spine with gadolinium, and cytologic evaluation of the cerebral spinal fluid. Therapy entails a multimodal approach focused on palliation with surgery, radiation, and/or chemotherapy, which may be administered systemically or directly into the cerebral spinal fluid. Limited trial data exist to guide treatment, and current regimens are based primarily on expert opinion. Although newer targeted and immunotherapeutic agents are under investigation and have shown promise, an improved understanding of the biology of leptomeningeal metastasis and treatment resistance as well as additional randomized controlled studies are needed to guide the optimal treatment of this devastating disease. Cancer 2018;124:21-35. © 2017 American Cancer Society.

Indexed as

Neurosurgical ProceduresRadiotherapyAntineoplastic AgentsAntineoplastic Agents, ImmunologicalCerebrospinal FluidCombined Modality TherapyContrast MediaDisease ManagementGadoliniumHumansInjections, SpinalMagnetic Resonance ImagingMeningeal CarcinomatosisMeningeal NeoplasmsAntineoplastic AgentsAntineoplastic Agents, ImmunologicalContrast MediaGadoliniumbrain metastasiscarcinomatous meningitisleptomeningeal carcinomatosisleptomeningeal diseaseleptomeningeal metastasis

Identifiers

PMID29165794
PMCPMC7418844
OpenAlexW2768584883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.